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Case presentation
A 59-year-old woman was transferred to New England Medical
Center (NEMC) for evaluation of carcinoma of the lung, profound
hypokalemia, and metabolic alkalosis. The patient, who smoked one
pack of cigarettes daily for 25 years, was well until 4 months prior to
admission, when she developed bilateral ankle edema, nocturia, dysp-
nea on exertion, and facial puffiness. She gained 20 pounds in one
month and also suffered from progressive muscle weakness. She
consulted her physician, who prescribed 5 mg of methychlothiazide
(Enduron) daily; her weight fell and ankle edema lessened, but the other
symptoms did not improve.
She was admifted to a local hospital, where the following laboratory
data were obtained: serum sodium, 146 mEq/liter; serum potassium, 1.2
mEq/liter; serum chloride, 67 mEq/liter; total CO2, 66 mmol/liter; blood
pH, 7.65; and PaCO2, 60 mm Hg (Table 1). She was treated with
potassium chloride orally and intravenously, but by the second hospital
day the serum potassium had increased to only 1.7 mEq/liter, and the
24-hour urinary potassium excretion was 218 mEq; urine sodium was
257 mEq. Over the next 3 weeks serum potassium averaged 2.6 mEq/
liter, although the patient was receiving large doses of potassium
chloride (Fig. 1).
Plain chest films showed a left lower lobe infiltrate and collapse and a
left pleural effusion. An obstructing endobronchial lesion of the left
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lower lobe bronchus was biopsied during bronchoscopy. The patient
was given 100 mg/day of spironolactone as well as the oral potassium
supplements and was referred to NEMC for further evaluation.
On examination she was deeply tanned, appeared chronically ill, and
had hyperpigmentation of the palmar creases. Blood pressure was 140/
80mm Hg; pulse, 70; respiratory rate, 24/mm; and temperature, 37.3°C.
Head and neck examination were unremarkable. Chest examination
revealed dullness to percussion at both bases with poor air entry
bilaterally. Inspiratory and expiratory rhonchi were heard over the right
lung field. Examination of the heart disclosed an S4 and normal Sl and
S2 sounds; a grade TI/VT systolic murmur was present at the apex.
Abdominal examination revealed the liver edge to be at the costal
margin. She had 1+ pitting edema in the legs. Diffuse muscular
weakness was present. Laboratory data were: sodium, 143 mEq/liter;
potassium, 2.5 mEq/liter; chloride, 94 mEq/liter; total CO2, 45 mmol/
liter; BUN, 15 mg/dl; creatinine, 0.6 mg/dl; pH, 7.54; Pa02, 54 mm Hg
(on room air); PaCO2, 50 mm Hg; blood glucose, 171 mg/dl; serum
albumin, 2.9 g/dl; white blood cell count, 15,400/mm3; hemoglobin, 11.9
g/dl; hematocrit, 37%; platelet count, 284,000/mm3; and serum calcium,
7.8 mg/dl. Urinalysis revealed a pH of 7.0; specific gravity, 1.014; a
trace of protein; 3+ glucose; and 1 to 3 white cells per high-power field.
Electrocardiogram was normal and chest radiographs showed a small
left pleural effusion. Plasma ACTH was 3887 pglml (normal up to 100
pg/mI) and plasma aldosterone was 43.3 ng/dl (normal 5 to 30 ng/dl).
Morning plasma cortisol measured 35.0 mg/dl; evening plasma cortisol,
42.4 mg/dl; urinary 17-hydroxycorticosteroids, 127 mg/24 hr (normal 3
to 10 mg/24 hr); urinary free cortisol, 14,957 mg/24 hr (normal 100 to 375
mg/24 hr).
The biopsy showed a small cell, undifferentiated carcinoma compati-
ble with oat cell carcinoma of the lung. Brain, bone, and liver scans
showed no evidence of metastatic disease. A CT scan of the chest
revealed a large left hilar tumor compressing the left main stem
bronchus and the bronchus of the left lower lobe with metastases to
mediastinal lymph nodes.
The patient was treated with CCNU, methotrexate, and cyclosphos-
phamide, which she tolerated well. She also was given a dietary
potassium supplement (40 mEq orally 4 times daily) and spironolactone,
200 mg, 3 times daily; her dietary sodium was restricted to 1 g/day. This
regimen sustained serum potassium at 4.5 mEq/liter and total CO2
content at approximately 35 mmol/liter.
Discussion
DR. JOHN T. HARRINGTON (Professor of Medicine, Tufts
University School of Medicine, and Chief, General Medicine
Division, New England Medical Center, Boston, Mass.). Meta-
bolic alkalosis, defined as a primary increment in plasma
bicarbonate concentration, has been a subject of intense inter-
est to acid-base physiologists and to clinicians over the last
several decades, and it remains so [1—91. I plan to discuss
several aspects of the patient presented, especially the initially
elevated PaCO2, review present concepts regarding the mainte-
nance of both chloride-resistant and chloride-responsive chronic
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Table 1. Selected laboratory data
Days following first hospitalization
0 1 2 3
Serum potassium
(mEqiliter) 1.2 1.7 2.3 2.3
Blood pH 7.65 7.63 7.59 7.57
PaCO2
(mm Hg) 60 57 53 53
Plasma HCO3
(mEqiliter) 65 58 49 47
PaCO2* 0.5 0.5 0.5 0.6
HC03
* Represents the ratio of the increase above the normal PaCO2 of 40
mm Hg and the normal bicarbonate concentration of 24 mEq/liter.
metabolic alkalosis [11, examine some new physiologic observa-
tions on experimental metabolic alkalosis, and conclude with a
brief synopsis of the treatment of metabolic alkalosis.
The metabolic alkalosis was severe in this patient, as were
the hypokalemia and the adaptive or secondary hypercapnia.
The diagnosis of chloride-resistant metabolic alkalosis due to an
ACTH-secreting bronchogenic carcinoma could easily have
been made given the information available within the first few
days of her admission to the local hospital. The precise cause of
metabolic alkalosis in an individual patient usually is identified
on the basis of the medical history and clinical setting, and
elaborate laboratory testing generally is not required. Diuretic
use or abuse and gastric acid loss secondary either to vomiting
or nasogastric drainage account for the vast majority of in-
stances of severe metabolic alkalosis. For today's purposes, I
will ignore the special case of metabolic alkalosis due to excess
alkali ingestion or administration [101; we then can conveniently
categorize metabolic alkalosis as either chloride-responsive or
chloride-resistant. Table 2 lists the common causes of metabolic
alkalosis in each of these categories. Although in this patient we
do not have the critical laboratory determination—that is, the
urinary chloride concentration—I am confident that the urine
chloride would have considerably exceeded 20 mEq/liter, even
ii the small dose of thiazides had been stopped. I say this
because the patient was receiving large amounts of potassium
chloride with little or no change in potassium or plasma chloride
concentration and without effect on the metabolic alkalosis.
Second, the glomerular filtration rate was normal, as measured
by a serum creatinine of 0.6 mgldl. We can surmise that the
patient was in a steady state and in chloride balance, that is, all
administered chloride was being excreted in the urine. Thus we
can reasonably conclude that this patient had chloride-resistant
alkalosis.
The differential diagnosis of chloride-resistant metabolic al-
kalosis comprises the disorders listed in the bottom half of
Table 2. Primary aldosteronism is not a consideration in this
patient because she was not hypertensive and because the
plasma bicarbonate concentration was much higher than that
typically seen in primary aldosteronism. Bartter's syndrome, a
rare disorder in adults, could have caused the acid-base abnor-
mality noted. Extensive endocrinologic investigation is needed
to definitively distinguish Bartter's syndrome from primary
aldosteronism and Cushing's syndrome, but determination of
plasma renin activity is a readily available method for making
this distinction. Increased renin secretion is a sine qua non for
patients with Bartter's syndrome, whereas in patients with
primary aldosteronism or Cushing's syndrome (who are volume
expanded), the renin level is suppressed. Although plasma renin
was not measured, there is no evidence to support a diagnosis
of Bartter's syndrome. Moreover, we have a better reason for
the chloride-resistant alkalosis.
In the patient we are discussing, the long history of smoking,
the finding of severe metabolic alkalosis resistant to chloride
administration, and the results of bronchoscopy virtually con-
firm the diagnosis of an ACTH-secreting bronchogenic carcino-
ma [Il, 121 even without special endocrinologic studies. After
the lesion was diagnosed, treatment was instituted both for the
major disorder in this patient—the bronchogenic carcinoma—as
well as for the paraneoplastic problem of interest to us today. 1
should reiterate that aggressive, conventional, oral and intrave-
nous treatment with potassium and chloride failed to totally
correct the alkalosis and the hypokalemia.
The greatly elevated plasma bicarbonate concentration in this
patient with Cushing's syndrome secondary to an ACTH-
secreting tumor is intriguing. In a recent review of extreme
metabolic alkalosis, we found that plasma bicarbonate concen-
trations greater than 60 mmol/liter virtually never occur save in
patients with chloride-responsive gastric alkalosis [1]. What
accounts for the plasma bicarbonate concentration of 66 mmol/
liter when this patient was first examined? The first possibility
is that hypersecretion of steroids explains the unusual eleva-
tion. The data in this patient suggest excess aldosterone secre-
tion, a finding that is not typical of Cushing's syndrome due to a
malignancy 13]. The excess aldosterone secretion, whatever its
cause, could have contributed to the rise in the plasma bicar-
bonate concentration. A second possibility is that the patient
has a mixed metabolic alkalosis: in addition to having metabolic
alkalosis due to the demonstrated ACTH excess, she had
gastric or diuretic-induced alkalosis as well. She had no history
of vomiting or nasogastric drainage, however, and I cannot
advance this possibility further. The third possibility is that
severe potassium deficiency contributed to the genesis and
maintenance of this patient's chloride-resistant metabolic alka-
losis. We will return to this issue later.
The hypercapnia of metabolic alkalosis
I would like to address a series of questions regarding the
elevated PaCO2 when the patient was admitted to a local
hospital. First, what degree of hypercapnia should be anticipat.
ed for a given rise in plasma bicarbonate concentration in
patients with metabolic alkalosis? A related question, did this
patient have hypercapnia of a magnitude greater than that
attributed to metabolic alkalosis alone? Finally, how helpful
was the rise in PaCO2 in defending against severe alkalemia?
The quantitative aspects of the human ventilatory response to
metabolic alkalosis remain poorly defined. Experimental stud-
ies in dogs and rats have shown that as plasma bicarbonate
concentration rises, PaCO2 also increases. In animals, the
change in PaCO2 with respect to the change in plasma bicarbon-
ate (PaCO2/XHCO3), varies from 0.55 to 0.70 mm Hg/mEq/
liter [14—17], Limited data in humans, including observations in
dialyzed patients [18], indicate that the relationship approxi-
mates 0.7 mm Hg/mEq/liter for plasma bicarbonate concentra-
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Days after first hospital admission
Primary aldosteronism
Bartter' s syndrome
Cushing's syndrome
Disorders that simulate adrenocortical excess
Idiopathic
tions up to 40 mEq/liter [1]. To define the APaCO2/HCO3
relationship for levels of plasma bicarbonate greater than 40
mEq/Iiter, we carefully selected from the literature patients
with plasma bicarbonate concentrations of 40 to 75 mEq/liter
[1]. Patients with respiratory disease or other factors known to
suppress ventilation were excluded from the analysis. The
evidence that the patients had only metabolic alkalosis and not
a complicating respiratory acidosis derives from two compelling
observations: (1) when plasma bicarbonate concentration was
restored to normal, PaCO2 also fell to normal; and (2) pulmo-
nary function tests carried out after correction of the metabolic
alkalosis were normal. Figure 2 represents acid-base data from
the 19 selected patients; the open circles represent their acid-
base data. Even at extreme levels of alkalosis, there is increas-
ing hypercapnia; that is, the iPaCO2/HCO3 relationship does
not appear to reach a plateau. Values for PaCO2 even greater
IHCO3I m Eq/I
Fig. 2: Respiratory adaptation in metabolic alkalosis. The dashed line
represents the mean "whole-body titration" response approximated
from available data and defines the increment in PaCO2 attributable to
increments in plasma bicarbonate concentration. On average, each
mEq/liter rise in plasma bicarbonate is associated with a 0.7 mm Hg rise
in PaCO2. The dashed line is not extended beyond a bicarbonate
concentration of 40 mEq/liter because no systematic observations are
available at higher levels (open circles represent the acid-base data from
the 19 selected patients) (from Ref. 46).
than 70 mm Hg have been observed, and respiratory failure has
been reported. Thus, in answer to my first question, the mean
slope of the PaCO2/HCO3 relationship in humans with
metabolic alkalosis and with plasma HC03 concentrations less
than 40 mEq/liter is approximately 0.7 mm Hg per mEq/liter [11.
The data from the 19 patients suggest, but do not prove, that the
slope of the relationship remains at approximately 0.7 even in
patients with plasma bicarbonate concentrations greater than 40
mEq/liter.
The principal receptors responsible for the rise in PaCO2 (that
-
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Table 2. Causes of metabolic alkalosis
Fig. 1: Clinical course of patient during month
after first hospital admission. Daily doses of
spironolactone, potassium citrate, and
potassium chloride are shown above, and
serial TCO2 contents and serum potassium
levels are plotted below PaCO2.
A. Chloride-responsive alkalosis
Gastric fluid losses
Diuretic therapy
Posthypercapnic state
Stool losses
Congenital chloridorrhea
Villous adenoma
B. Chloride-resistant alkalosis
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Fig. 3: Effects of persistent, secondary
hypercapnia on plasma bicarbonate
Concentration during chronic diuretic-induced
metabolic alkalosis. Steady-state values for
PaCO2 are shown on the left and for
bicarbonate concentration on the right. Each
point represents the average of 3 observations
obtained on consecutive days in a single dog
(from Ref. 19).
is, the decrease in ventilation) in metabolic alkalosis reside in
the central nervous system. Clear evidence in the dog indicates
that cerebrospinal fluid bicarbonate concentration rises as
plasma bicarbonate concentration rises; no change in the usual
CSF-arterial PCO2 gradient occurs [15]. As a consequence,
CSF acidity decreases, in turn resulting in a depression of
minute ventilation. Limited data in humans with severe meta-
bolic alkalosis suggest that a similar degree of CSF alkalinity
occurs, thus accounting for the secondary hypercapnia [1].
Table 1 shows that the PaCO2/HCO3 ratio in this patient
varied between 0.5 and 0.6 for the first 3 days of observation.
These findings are close to the ratio of 0.7 I have just presented.
Although pulmonary function tests were not performed in this
patient, no evidence of clinically significant respiratory disease
was apparent from the medical history or physical examination.
Thus I believe that metabolic alkalosis was a sufficient explana-
tion for the patient's hypercapnia.
I have not yet answered the final question: was the striking
increase in PaCO2 entirely beneficial to the patient? Most of us,
I believe, have accepted the intuitively attractive notion that the
rise in PaCO2 in metabolic alkalosis is salutary with respect to
the body's hydrogen ion concentration. Although logical, this
concept is now known to be only partially correct. Recent
studies show that hypercapnia causes the kidney to increase
acid excretion and to generate new bicarbonate—not only in
primary respiratory acidosis, but also in the secondary hyper-
capnia associated with metabolic alkalosis [19]. To demonstrate
this effect, metabolic alkalosis was induced in dogs by the
administration of ethacrynic acid and a chloride-free diet. After
a steady state of plasma composition had been achieved, the
secondary hypercapnia of metabolic alkalosis was abolished by
hypoxemia-induced hyperventilation. The PaCO2 fell to control
values; observations were continued over the next several
days, and the animals then were allowed to recover. Figure 3
documents the effect of the secondary hypercapnia on plasma
bicarbonate concentration in this model of diuretic-induced
metabolic alkalosis [19]. The PaCO2 was 36 mm Hg and
bicarbonate 23 mEq/liter in the control period. When metabolic
alkalosis was produced, the plasma bicarbonate concentration
rose to 31 mEq/liter and the PaCO2 rose, as anticipated, to 41
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mm Hg; when secondary hypercapnia was abolished by hypox-
emia, the PaCO2 fell to its control value of 36 mm Hg and, in
response, the plasma bicarbonate concentration decreased to 27
mEq/liter. No change in plasma lactate was noted. When
secondary hypercapnia was reestablished in the final period,
the plasma bicarbonate concentration again rose to 31 mEq/liter
in concert with the return of the PaCO2 to its previous level.
These studies indicated that fully 40% of the change in plasma
bicarbonate in this model of chronic metabolic alkalosis is not a
consequence of the "metabolic" abnormality per Se, but is due
to a direct effect of the secondary change in PaCO2 on renal acid
excretion and bicarbonate reabsorption. The alteration in plas-
ma bicarbonate concentration in chronic metabolic alkalosis
thus has a dual genesis. One element of the hyperbicarbonate-
mia is related to the factor that generated the alkalosis initially,
whereas a second element is related to the "maladaptive" renal
response to the secondary hypercapnia [191. Because the stud-
ies of the secondary hypercapnia of metabolic alkalosis were
limited to a small increase in plasma bicarbonate, it is difficult to
extrapolate quantitatively from those experimental data to
specific clinical situations. Nevertheless, one can assume from
these data that some fraction of the increment in plasma
bicarbonate concentration in the patient under discussion today
was due to the secondary hypercapnia. I conclude that while
the rise in PaCO2 does mitigate severe changes in pH in patients
with chronic metabolic alkalosis and is beneficial, its salutary
impact is dampened by the "maladaptive" renal response.
This direct impact of a rise in PaCO2, whether primary or
secondary, on renal acid excretion gains credence from analo-
gous studies in metabolic acidosis. Figure 4 shows the major
findings in a study designed to divorce the effect of hydrochloric
acid feeding per se on plasma bicarbonate concentration from
the potential effect of the secondary hypocapnia that usually
accompanies metabolic acidosis [201. First, in the control
setting, PaCO2 was 36 mm Hg and plasma bicarbonate 21 mEq/
liter, typical values for normal dogs. With hydrochloric acid
feeding (7 mmol/kglday), but with secondary hypocapnia pre-
vented by an elevated ambient CO2 concentration, plasma
bicarbonate concentration fell from 21 mEq/liter to 16 mEq/
liter, a reduction less than that commonly observed in this
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Fig. 4: Effects of persistent spontaneous hypocapnia on plasma bicar-
bonate concentration during chronic HCI acidosis. Steady-state values
for PaCO2 are shown on the left and for bicarbonate concentration on
the right. Each point represents the average of three observations
obtained on consecutive days in a single dog. PaCO2 was maintained at
control levels during eucapnic HCI acidosis but fell significantly during
the period of spontaneous hypocapnia (mean PaCO2 6 mm Hg).
Reproduced from The Journal of Clinical Investigation, 1977, vol. 60,
pp. 1393—1401, by copyright permission of the American Society for
Clinical Investigation.
experimental model of metabolic acidosis [211. However, when
the PaCO2 was allowed to fall from 36 to 30 mm Hg—the
spontaneous hypocapnia of metabolic acidosis—plasma bicar-
bonate concentration fell further from 16 mEq/liter to 13 mEq/
liter. The data thus demonstrate quite clearly that the decline in
plasma bicarbonate concentration in chronic HCI acidosis has
two components: one element of the decline results from the
acid load itself, but a substantial portion, some 40% of the
decrement, results from the effect of PaCO2 on plasma bicar-
bonate concentration. This is remarkably similar to the 40%
increase in plasma bicarbonate concentration due to the sec-
ondary hypercapnia of experimental, diuretic-induced metabol-
ic alkalosis. It is apparent from these studies that the kidney
sets its rate of bicarbonate reclamation by the prevailing PaCO2
and that it does so whether the change in PaCO2 is a primary or
secondary phenomenon.
Mechanisms of persistent hyperbicarbonatemia in metabolic
alkalosis
I have just concluded that some portion of the elevated
plasma bicarbonate concentration in this patient was related to
the secondary hypercapnia—but that clearly is not the whole
story. Something has to raise plasma bicarbonate concentration
in the first place, and then some factors must act in concert to
maintain the elevated level [22]. Why didn't this patient simply
excrete the excess bicarbonate in the urine, as a normal
individual would if sufficient sodium bicarbonate were adminis-
tered to raise plasma bicarbonate? This remains the critical
question in understanding persistent metabolic alkalosis. Over
the years, persistent alkalosis has been attributed to sodium
depletion, potassium depletion, chloride depletion, excess glu-
cocorticoid, excess mineralocorticoid, or a combination of
these factors [1]. Recently it was suggested that a reduction in
glomerular filtration rate is necessary for the maintenance of
metabolic alkalosis in at least one experimental model [23].
Before discussing this issue in detail, I would like briefly to
review the maintenance of the two major types of metabolic
alkalosis, chloride-responsive and chloride-resistant alkalosis.
Chloride-responsive alkalosis. Studies in the l960s using an
experimental model of one of the common types of metabolic
alkalosis, that due to loss of acid gastric juice, demonstrated
that the increased renal hydrogen ion secretion required to
maintain an elevated plasma bicarbonate concentration could
be attributed to a combination of sodium avidity and diminished
chloride availability [6—91. I stress sodium avidity; overt sodium
depletion is not required either in experimental animals or in
normal human volunteers.
After selective depletion of hydrochloric acid in normal
humans (produced by gastric acid drainage and replacement of
any NaC1 and KCI removed), plasma bicarbonate concentration
rose to 40 mEq/liter or more, and plasma chloride concentration
fell in a reciprocal fashion [81. Substantial negative chloride (via
gastric losses) and potassium (via renal losses) balance ensued
and persisted as long as the diet remained chloride free. One
can correct the gastric alkalosis by administering either NaCl
without potassium or KC1 without sodium. These normal
individuals lost less than 100 mEq of sodium in the urine, had no
evidence of volume contraction, and maintained inulin clear-
ances during the period of alkalosis at levels unchanged from
control [81. These latter observations are particularly notewor-
thy in light of the recent study by Cogan and Liu [23], who
conclude that a decline in GFR is critical to the persistence of
metabolic alkalosis. The observation by Cohen that diuretic-
induced metabolic alkalosis in the dog could be corrected by
rapid infusion of a solution that mimicked the plasma composi-
tion of the alkalemic animals gives further weight to the
hypothesis that both sodium avidity and chloride depletion are
required to perpetuate metabolic alkalosis [24].
Chloride-resistant alkalosis. In the patient under discussion,
chloride depletion cannot account for the persistent hyperbicar-
bonatemia. But what does maintain the alkalosis in this group of
patients? Unfortunately, we do not know. Increased secretion
of glucocorticoids (in this patient, secondary to ACTH produc-
tion by the bronchogenic carcinoma), increased secretion of
mineralocorticoids, and severe potassium depletion have been
considered the agents or factors most likely to be responsible
[1]. In this patient, the severe potassium depletion (serum
potassium was 1.2 mEq/liter) might have contributed to the
maintenance of the alkalosis. Hulter, Licht, and Sebastian have
shown that potassium depletion potentiates the effect of miner-
alocorticoids on renal acid excretion [25]. Clinically, extreme
hypokalemia has been found in a small but interesting group of
patients with so-called idiopathic chloride-resistant alkalosis.
Plasma bicarbonate concentration in these patients varies from
35 to 47 mEq/liter, and potassium concentrations range from
less than 1.0 to 2,1 mEq/liter. One patient, studied during
recovery from the alkalosis, retained nearly 1000 mEq of
potassium, emphasizing the profound degree of potassium
depletion present in these unusual patients [26].
I should point out that experimental studies of isolated
potassium depletion (produced by dietary restriction) conflict.
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Although potassium depletion causes net acid excretion to fall
in dogs and in humans, plasma bicarbonate rises slightly in
humans [27] and actually falls slightly in dogs [281. In neither
species can severe metabolic alkalosis be produced by pure
potassium depletion.
Role of GFR in the persistence of metabolic alkalosis
If the glomerular filtration rate always were depressed in
metabolic alkalosis, as it probably is in alkalotic patients salt-
depleted from vomiting or taking diuretics, one could argue that
the fall in GFR and the consequent decrease in filtered bicar-
bonate load might be sufficiently great to perpetuate the alkalo-
sis without the need for invoking enhanced absolute tubular
bicarbonate reabsorption. As I mentioned, Cogan and Liu have
claimed recently that just such a reduction in GFR does occur
and is critical to the maintenance of metabolic alkalosis [23].
They carried out a series of micropuncture and clearance
experiments in rats with chronic metabolic alkalosis and vary-
ing degrees of potassium and chloride deficiency [23] and
compared their results to those obtained in previous studies in
normal rats [29]. Metabolic alkalosis was induced by feeding the
animals an electrolyte-deficient diet supplemented with sodium
sulfate and sodium bicarbonate, and by injecting deoxycorticos-
terone acetate. Severe metabolic alkalosis was produced; pH
was 7.57 and total CO2 41 mmollliter. In these animals, whole-
kidney and single-nephron glomerular filtration rate declined
sufficiently to leave the filtered load of HCO3 unchanged as
compared to the non-current, unpaired euvolemic controls [29].
Similarly, absolute proximal HC03 reabsorption and distal
HC03 delivery did not differ in the two groups. The authors
concluded that the demonstrated fall in GFR permitted normal
rates of renal tubular hydrogen ion secretion to maintain the
alkalotic state. Isohydric expansion in an additional 10 rats with
metabolic alkalosis produced an increase in GFR and a de-
crease in fractional proximal HC03 reabsorption.
The data are interesting and the authors' conclusions provoc-
ative, but let us examine the interpretation of these data. Using
the clearance data, Cogan and Liu demonstrate only a correla-
tion between the changes in single-nephron GFR and the
changes in plasma bicarbonate concentration; they do not show
that one is causally related to the other. More important,
individual data points are not shown, simply the means, and
individual data points are crucial for determining whether the
GFR is the critical determinant of the elevated plasma bicarbon-
ate concentration in chronic metabolic alkalosis. The authors
do demonstrate that alterations in proximal tubular renal acidifi-
cation seem not to be regulated by changes in systemic pH; this
view is consistent with the hypothesis advanced by Schwartz
and Cohen [301.
Studies by two different groups help to shed light on the role
of GFR in the maintenance of metabolic alkalosis. First, the
studies of Maddox and Gennari [31] conflict with those of
Cogan and Liu. Metabolic alkalosis was produced in rats by
provision of a chloride-free and potassium-restricted diet, injec-
tion of furosemide, and administration of sodium bicarbonate in
the drinking water. Animals with metabolic alkalosis had a
stable elevated plasma bicarbonate concentration throughout a
2-week observation period. At 11 to 14 days, single-nephron
GFR was 24 nl/min, a figure not significantly different from
control. In addition, whole-kidney GFR, initially 1.2 mI/mm,
SNGFR
(ni/mm)
Fig. 5: Relationship between SNGFR and APRHCO3 in control rats(open symbols and dotted line) and in rats with CMA (filled symbols
and solid line). The lines drawn through the data points were obtained
by least-squares analysis. The two lines have similar slopes, but
significantly different intercepts (p < 0.01) by covariance analysis.
Reproduced from The Journal of Clinical Investigation, 1983, vol. 72,
pp. 1385—1395 by copyright permission of The American Society for
Clinical investigation.
was 1,0 ml/min (not significantly different from control) at 11 to
14 days. When filtered bicarbonate load was plotted against
absolute plasma bicarbonate concentration at 11 to 14 days, a
higher rate of proximal bicarbonate reabsorption was found in 5
of 7 rats in which single-nephron GFR was not different from
control.
Maddox and Gennari plotted absolute proximal bicarbonate
reabsorption (APRHCO3) against single-nephron GFR
(SNGFR) in control animals and in animals with chronic
metabolic alkalosis (CMA) and obtained two parallel lines (Fig.
5). They thus demonstrated that proximal bicarbonate reab-
sorption is simply delivery related, a situation entirely analo-
gous to the proximal tubular control of sodium reabsorption
[32]. These data suggest that glomerular filtration rate and
luminal bicarbonate concentration are not the critical factors; it
appears that it does not matter how bicarbonate delivery is
increased; it is the increased bicarbonate delivery per se that is
important.
Galla, Bonduris, and Luke also studied the impact of volume
expansion and changes in GFR on correction of metabolic
alkalosis [33]. These investigators studied the relative impor-
tance of volume expansion versus the availability of chloride in
the correction of experimental metabolic alkalosis induced by
peritoneal dialysis. In experimental rats, provision of chloride
with either sodium or choline corrected the alkalosis despite a
continued negative potassium balance. Volume expansion did
not occur in the choline chloride-treated animals, and Galla et al
thus concluded that chloride depletion accounted for the main-
tenance of the metabolic alkalosis [33—35]. Although single-
nephron GFR was not determined in their study [331, it seems
unlikely that the correction phase was associated with an
increase in SNGFR, given the absence of volume expansion in
the choline chloride-treated animals.
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Treatment of metabolic alkalosis
Treatment of the common type of chloride-sensitive metabol-
ic alkalosis usually requires only correction of chloride deple-
tion, restoration of extracellular volume (if depleted), and the
provision of an adequate amount of potassium. Most patients
with metabolic alkalosis respond rapidly to intravenous infu-
sions of 2 to 3 liters/day of normal saline with 40 to 60 mEq of
KCI in each liter. When alkalosis is severe (arbitrarily defined
as a plasma bicarbonate concentration of 40 mEq/liter), more
aggressive measures are required, including treatment with
ammonium chloride, arginine hydrochloride, hydrochloric acid,
or acetazolamide. Even hemodialysis has been proposed. My
own practice in these unusual circumstances—and I have done
this usually in patients with severe secondary hypercapnia or
digitalis intoxication from concomitant hypokalemia—has been
either to infuse 0.1 N hydrochloric acid through a central vein,
or argininc hydrochloride through a peripheral vein, monitoring
serum potassium carefully. Recently Knutsen showed that the
administration of hydrochloric acid through a peripheral line is
feasible by adding 0.15 N hydrochloric acid to an amino acid
solution and fat emulsion [361. This approach has the advantage
of not requiring a central venous catheter and should be
considered in the unusually severe case of metabolic alkalosis.
Treatment of chloride-resistant metabolic alkalosis is much
more difficult, as demonstrated by the patient under discussion
today. Therapy consists of the administration of large amounts
of KC1, the use of spironolactone in maximal doses in hyperad-
renal states, and an attack on the root cause of the alkalosis.
Examples include surgical treatment of primary aldosteronism
and treatment with prostaglandin synthetase inhibitors in pa-
tients with Bartter's syndrome.
Questions and answers
DR. JEROME P. KASSIRER: I would like to make two com-
ments on the pathogenesis of metabolic alkalosis. First, I
assumed that a reduction in GFR had been dismissed as an
important factor in the pathogenesis of persistent alkalosis by
the extensive studies by Schwartz and colleagues in animals
and humans. Both in gastric alkalosis in dogs and humans and in
sodium nitrate-induced alkalosis in humans, inulin or creatinine
clearances performed during steady-state alkalosis are un-
changed as compared to controls [7, 8, 37]. These observations
in intact animals and humans argue strongly against a fall in
GFR as a necessary pathogenetic element. I continue to believe
that in gastric and diuretic-induced alkalosis, the principal
mechanism for persistent alkalosis is the disproportion between
sodium reabsorption and chloride availability.
My second comment relates to the pathogenesis of steroid-
induced metabolic alkalosis. The question is whether there is
any relevance between experimental steroid-induced alkalosis
and the clinical alkalosis that occurs in primary aldosteronism
or Cushing's syndrome. In all the experimental forms of steroid
alkalosis, some nonphysiologic combination of diet and electro-
lyte supplement is required to produce alkalosis; in the case of
the studies by Cogan and Liu [23], Hulter and colleagues [25],
and us [38], either sodium sulfate or bicarbonate must be given
with the steroids, or else plasma bicarbonate rises little. In fact,
if one administers large quantities of aldosterone to normal
individuals ingesting a normal diet for as long as 3 months,
plasma bicarbonate increases 2 or 3 mEq/liter after a few days
and does not increase thereafter [39]. Thus we are stuck with
the dilemma that manipulations not relevant to human alkalosis
are needed in these experimental models. Presumably the
steroid itself influences renal hydrogen secretion, but a model
to test this hypothesis has not yet surfaced.
DR. HARRINGTON: I fully agree with your comments, which
seem to contain one basic question: How analogous to gastric
alkalosis in humans are the models of metabolic alkalosis in
rats? The answer is that they aren't analogous at all. To perform
micropuncture studies and determine whether and where along
the nephron enhanced bicarbonate reabsorption occurs, it is
necessary to work with these complex models. I should point
out that in the Maddox and Gennari study [311, administration
of bicarbonate in the drinking water was required to sustain the
metabolic alkalosis induced by furosemide. It is a lyric leap
from these kinds of experimental models to real-world gastric
alkalosis. Dr. Gennari, do you want to comment?
DR. F. JOHN GENNARI (Professor of Medicine, and Chief,
Renal Division, Univ. of Vermont College of Medicine, Burling-
ton, Vermont): Yes. First, I agree with Dr. Kassirer. The
experiments he and Dr. Schwartz carried out provide definitive
evidence that a reduction in GFR is not required for the
maintenance of chloride depletion alkalosis in humans [8]. If
GFR doesn't change, and the plasma bicarbonate concentration
is maintained at 40 mEq/liter, the kidneys are obviously reab-
sorbing much more bicarbonate than normal. In the two micro-
puncture studies in the rat that were discussed in this Forum,
the fall in GFR is most likely due to a concomitant fall in
extracellular fluid volume [23, 31]. In contrast to the experi-
ments reported by Kassirer and Schwartz, NaCl losses were
not specifically replaced in either study. In their model of
metabolic alkalosis in the rat, Cogan and Liu found a close
correlation between the degree of chloride depletion and the
magnitude of the fall in GFR [23]. To go from this close
correlation to the conclusion that a fall in GFR is a necessary
condition for maintenance of the metabolic alkalosis, however,
is unjustified. The demonstration by these investigators that
chloride repletion (induced by acute isometric expansion) both
increases GFR and reduces bicarbonate reabsorption provides
insight into recovery from metabolic alkalosis, but not into the
maintenance of this acid-base disorder.
The observations Dr. Maddox and I made in a somewhat
different model of metabolic alkalosis in the rat are generally in
accord with the results of Cogan and Liu. The GFR tended to
fall in the chloride-depleted alkalotic rats, and mean proximal
tubular and overall renal bicarbonate reabsorption was not
significantly increased above control. In our study, however,
the rate of proximal bicarbonate reabsorption was higher than
the highest control value in 5 rats with metabolic alkalosis in
which GFR did not fall. If a reduction in GFR is truly critical for
the maintenance of alkalosis in the rat, we should not have seen
this finding. In both Cogan and Liu's study and ours, proximal
bicarbonate reabsorption varied in direct relation to the filtered
load in chronic metabolic alkalosis, and the relationship was
indistinguishable from that seen in control animals. I find it
interesting that neither severe hypokalemia nor alkalemia influ-
enced the pattern of proximal bicarbonate reabsorption in the
rats with chronic metabolic alkalosis. Instead, the filtered load
appears to be the overriding influence determining the rate of
proximal bicarbonate reabsorption. Given this relationship, it is
apparent that proximal bicarbonate reabsorption may be in-
creased, unchanged, or decreased as compared to control in
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chronic metabolic alkalosis, depending on the extent to which
GFR has fallen. Our data suggest that when GFR is not notably
reduced, metabolic alkalosis in the rat is maintained, at least in
part, by a load-dependent increase in proximal bicarbonate
reabsorption.
DR. NIcoLAos E. MADIAS: I should like to point out another
important discrepancy between the results of Cogan and Liu in
their complex model of metabolic alkalosis in the rat and those
of Cohen in ethacrynic acid-induced metabolic alkalosis in the
dog [24, 40]. As Dr. Harrington mentioned, Cohen showed that
infusion of alkalotic animals with a solution isometric to plasma
(with respect to major electrolytes), while preventing filtered
load from increasing by means of an aortic clamp, led to
suppression of absolute bicarbonate reabsorption, to bicarbona-
tuna, and to selective renal chloride retention. These data
clearly indicate that correction of metabolic alkalosis in the dog
does not depend on an increment in glomerular filtration rate.
In regard to mineralocorticoid-induced metabolic alkalosis, I
should like to reemphasize that prior potassium restriction
allows the generation of moderate degrees of hyperbicarbonate-
mia in the dog in the absence of co-administration of bicarbon-
ate [251. However, even this degree of metabolic alkalosis is
much less severe than the one usually occurring in patients with
primary aldosteronism [391. The pathogenesis of human mm-
eralocorticoid-induced metabolic alkalosis remains unclear.
DR. RONALD D. PERR0NE (Division of Nephrology, NEMC):
In Dr. Gennari's slide (Fig. 5), there is the same relationship
between absolute proximal bicarbonate reabsorption and fil-
tered load in controls and animals with metabolic alkalosis,
although there seems to be a higher set point in metabolic
alkalosis. Could you explain that?
DR. GENNARI: The two parallel lines that emerge when
proximal bicarbonate reabsorption is plotted against single-
nephron GFR in control animals and animals with metabolic
alkalosis simply underscore the fact that plasma bicarbonate
concentration is higher in rats with metabolic alkalosis. Al-
though this relationship indicates that bicarbonate reabsorption
is higher for any given level of GFR in metabolic alkalosis, I
don't believe that bicarbonate reabsorption is stimulated. The
filtered load, that is, SNGFR x Bowman's space [HC03], is
just higher in these animals. As indicated earlier, bicarbonate
reabsorption appears to be determined primarily by the filtered
load both under control conditions and during chronic metabol-
ic alkalosis. Our data indicate that the proximal tubule is
indifferent to whether the filtered load is altered by changes in
GFR or in bicarbonate concentration. Bicarbonate reabsorption
in the accessible portion of proximal tubule remains at about
80% to 85% of the filtered load regardless of whether plasma
bicarbonate concentration or SNGFR is altered in our studies.
It should be noted that this relationship between bicarbonate
delivery and reabsorption can be altered by acute changes in
extracellular volume and by acute alkalemia [41—45]. In micro-
perfusion experiments, potassium depletion also appears to be a
modifying influence [45]. For reasons that remain unclear, our
results suggest that alkalemia, hypokalemia, and extracellular
volume are not very important influences (or else they are
exactly counterbalanced) in chronic metabolic alkalosis.
Turning away from the GFR issue, let me ask Dr. Madias a
question. We know that the increase in bicarbonate concentra-
tion induced by chronic hypercapnia is a function of the
bicarbonate concentration prior to hypercapnia. Thus, I suspect
that the secondary hypercapnia in this patient increased plasma
bicarbonate concentration only slightly. Can you comment on
this point?
DR. MADIAS: As Dr. Harrington indicated, in our studies with
ethacrynic acid-induced metabolic alkalosis of moderate sever-
ity ([HCO3] of 7.7 mEq/liter), some 40% of the bicarbonate
increment was attributed not to the associated chloride and
volume deficits but to the renal response to the accompanying
secondary hypercapnia. The observed [HCO3]/PaCO2
slope was 0.61 mEq liter1 mm Hg [19]. Studies with
graded degrees of metabolic alkalosis will be required to
quantitatively answer Dr. Gennari's question.
DR. KASSIRER: I suspect that the higher the plasma bicarbon-
ate, the smaller fractional contribution there is to this maladapt-
ive phenomenon. The incremental PaCO2-induced increase in
plasma bicarbonate probably has a much larger impact on
adaptation when the bicarbonate is slightly elevated and less
when the bicarbonate is very high. Clearly these are specula-
tions that require further evaluation.
DR. MADIA5: The overall utility of the ventilatory response to
metabolic acid-base disorders for the living organism warrants
redefinition in view of our recent findings, summarized by Dr.
Harrington, that drew a sharp distinction between the impact of
PaCO2 changes on plasma acidity in acute versus chronic
derangements [19, 201. These observations brought into focus
the basic principle that a deviation in plasma pH resulting from
a primary change in plasma bicarbonate concentration is offset
to a maximal degree by a given secondary change in PaCO2 only
so long as plasma bicarbonate is not further altered. We
previously showed that this situation only prevails in acute
metabolic acid-base disorders, in which the observed ventila-
tory response does little to further alter the plasma bicarbonate
concentration. By contrast, in chronic metabolic acid-base
disorders, the potential benefits of the ventilatory adaptation in
stabilizing extracellular acidity are greatly undermined by a
maladaptive renal response to the changes in PaCO2 culminat-
ing in substantial, secondary changes in plasma bicarbonate
concentration. Our use of the term "maladaptive" refers to the
fact that this renal response clearly diminishes the degree to
which systemic acidity is protected by the ventilatory response
acutely. Indeed, experimental conditions can be arranged such
that the kidney's response to so-called "compensatory" hyper-
ventilation actually results in more severe acidemia than would
occur in the complete absence of secondary hypocapnia [201.
Because of these findings, we previously suggested that the
time-honored terms "compensatory hypercapnia or hypocap-
nia" be discarded in favor of the descriptive terms "secondary
(or adaptive) hypercapnia or hypocapnia."
DR. KASSIRER: Although it is true that the mechanisms
described by Dr. Madias do reduce the effectiveness of the
adaptive response, we should not lose sight of the striking
protective effect conferred by secondary hypercapnia. Figure 6,
reprinted from Acid-Base [46], shows the protective effect of
hypercapnia as compared to no adaptation, assuming the slope
of the PaCO2/HCO3 relationship to be 0.7: even with
exteme alkalosis, that is, plasma bicarbonate concentrations of
60 to 70 mEq/liter, the adaptive increase in PaCO2 prevents pH
from rising above 7.6.
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Fig. 6: Beneficial effect of respiratory adaptation on pH and hydrogen
ion concentration in metabolic alkalosis. See text (from Ref. 46).
DR. DAVID CAHAN (Chief of Nephrology, Faulkner Hospital,
Boston): Does hypokalemia enhance hydrogen ion secretion by
the nephron?
DR. HARRINGTON: The information we have reviewed today,
including Cogan and Liu's study and the Maddox and Gennari
study, shows that the degree of potassium depletion has no
impact on the relationship between SNGFR and absolute
proximal bicarbonate reabsorption. As I mentioned earlier,
potassium depletion in humans causes plasma bicarbonate to
rise only slightly [271 and in dogs causes mild but definite
metabolic acidosis [281.
DR. KASSIRER: Dr. Gennari, would you comment about the
relationship between potassium deficiency and ammonia pro-
duction? In particular, what is the effect on steady-state acid-
base equilibrium of an increase in ammonia production conse-
quent to potassium deficiency?
DR. GENNARI: The evidence is clear that potassium depletion
stimulates ammonia production [47]. Despite this change, acid
balance is unaffected; urine pH rises and titratable acid excre-
tion falls so that net acid excretion is unchanged. Potassium
depletion, per se, has no effect in plasma bicarbonate concen-
tration in humans, except perhaps where it is severe enough to
reduce potassium concentration to below 2 mEq/liter. In the
dog, it produces metabolic acidosis; in the rat it produces
metabolic alkalosis [48, 49]. The potassium depletion-induced
increase in bicarbonate concentration in the rat is thought to be
related to transcellular shifts rather than to direct stimulation of
bicarbonate reabsorption or to an increase in acid excretion.
DR. MADIAS: Recent studies in the isolated rabbit proximal
convoluted tubule perfused in vitro have shown that when bath
potassium concentration is progressively lowered, sodium
transport, as reflected by volume absorption, and acidification,
as reflected by net total CO2 absorption, are both inhibited
proportionately [50].
DR. FERGUS MOYLAN (Dept. of Pediatrics, Boston Floating
Hospital, NEMC): Dr. Harrington, do we still need to be
concerned about metabolic alkalosis in neonates being fed low-
chloride formulas?
DR. HARRINGTON: Yes and no. A few years ago, a number of
investigators reported metabolic alkalosis in several normoten-
sive infants fed a commercial soybean formula [5 1—53]. The
critical clinical observation in these patients was that the urine
chloride concentration was extraordinarily low; the chloride
concentration of the soybean formula was less than 2 mEqlliter
in contrast to a chloride concentration of 10 to 18 mEq/liter in
otherformulas and in human breast milk in most instances. This
type of alkalosis has disappeared with provision of adequate
chloride in the formula. So you don't have to concern yourself
regarding that type of metabolic alkalosis. However, the identi-
cal syndrome was observed recently in 2 infants fed only breast
milk. In these patients, the chloride content of the mother's
breast milk was found to be near zero for unknown reasons [54,
55]. Chloride-responsive metabolic alkalosis also has been
found, not too surprisingly, to be a significant clinical problem
in the current epidemic of anorexia nervosa [56].
DR. VINCENT CANZANELLO (Fellow, Division of Nephrolo-
gy, NEMC): You did not comment on the increased "anion
gap" in metabolic alkalosis. Can you describe its origin?
DR. HARRINGTON: Most of the elevation of the anion gap in
metabolic alkalosis derives from an increase in the net anionic
charge of plasma proteins, due both to their titration (from the
alkalemia per se) and to the elevated concentration of plasma
proteins consequent to extracellular volume depletion [57, 58].
The clinical relevance of this observation is that a modest
increase in the anion gap in this setting should not force the
clinician to assume that a coexistent "hidden" degree of
metabolic acidosis is present. Metabolic acidosis thus is not the
only cause of an elevated anion gap.
Reprint requests to Dr. J. Harrington, Box 212, New England
Medical Center, 171 Harrison Avenue, Boston, Massachusetts 02111,
USA
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